Eph Receptor Tyrosine Kinases in Tumor Immunity

被引:53
作者
Shiuan, Eileen [1 ,2 ]
Chen, Jin [1 ,3 ,4 ,5 ,6 ]
机构
[1] Vanderbilt Univ, Sch Med, Dept Canc Biol, Nashville, TN 37212 USA
[2] Vanderbilt Univ, Med Scientist Training Program, 221 Kirkland Hall, Nashville, TN 37235 USA
[3] Vanderbilt Univ, Dept Med, Div Rheumatol & Immunol, Nashville, TN USA
[4] Vanderbilt Univ, Sch Med, Vanderbilt Ingram Canc Ctr, Nashville, TN 37212 USA
[5] Vanderbilt Univ, Dept Cell & Dev Biol, 221 Kirkland Hall, Nashville, TN 37235 USA
[6] Tennessee Valley Healthcare Syst, Vet Affairs Med Ctr, Nashville, TN USA
关键词
GLIOMA-ASSOCIATED ANTIGEN; INFLAMMATORY RESPONSE; STIMULATES MIGRATION; CELL-MIGRATION; ACTIVATION; EPHRIN-B2; PROMOTES; VACCINES; STEM; IDENTIFICATION;
D O I
10.1158/0008-5472.CAN-16-1521
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The family of Eph receptor tyrosine kinases and their ephrin ligands regulate a diverse array of physiologic processes, such as axonal guidance, bone remodeling, and immune cell development and trafficking. Eph/ephrin interactions have also been implicated in various pathologic processes, including inflammation, cancer, and tumor angiogenesis. Because Eph receptors play prominent roles in both the immune system and cancer, they likely impact the tumor immune microenvironment, an area in which Eph receptors remain understudied. Here, we provide the first comprehensive review of Eph receptors in the context of tumor immunity. With the recent rise of cancer immunotherapies as promising therapeutic interventions, further elucidation of the roles of Eph receptors in the tumor immune microenvironment will be critical for understanding and developing novel targets against tumor immune evasion. (C) 2016 AACR.
引用
收藏
页码:6452 / 6457
页数:6
相关论文
共 51 条
  • [31] Induction of Robust Type-I CD8+ T-cell Responses in WHO Grade 2 Low-Grade Glioma Patients Receiving Peptide-Based Vaccines in Combination with Poly-ICLC
    Okada, Hideho
    Butterfield, Lisa H.
    Hamilton, Ronald L.
    Hoji, Aki
    Sakaki, Masashi
    Ahn, Brian J.
    Kohanbash, Gary
    Drappatz, Jan
    Engh, Johnathan
    Amankulor, Nduka
    Lively, Mark O.
    Chan, Michael D.
    Salazar, Andres M.
    Shaw, Edward G.
    Potter, Douglas M.
    Lieberman, Frank S.
    [J]. CLINICAL CANCER RESEARCH, 2015, 21 (02) : 286 - 294
  • [32] Capillary Defects and Exaggerated Inflammatory Response in the Airways of EphA2-Deficient Mice
    Okazaki, Tatsuma
    Ni, Amy
    Baluk, Peter
    Ayei, Oluwasheyi A.
    Kearley, Jennifer
    Coyle, Anthony J.
    Humbles, Alison
    McDonald, Donald M.
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2009, 174 (06) : 2388 - 2399
  • [33] Eph receptors and ephrins in cancer: bidirectional signalling and beyond
    Pasquale, Elena B.
    [J]. NATURE REVIEWS CANCER, 2010, 10 (03) : 165 - 180
  • [34] Involvement of endothelial ephrin-B2 in adhesion and transmigration of EphB-receptor-expressing monocytes
    Pfaff, Dennis
    Heroult, Melanie
    Riedel, Maria
    Reiss, Yvonne
    Kirmse, Robert
    Ludwig, Thomas
    Korff, Thomas
    Hecker, Markus
    Augustin, Hellmut G.
    [J]. JOURNAL OF CELL SCIENCE, 2008, 121 (22) : 3842 - 3850
  • [35] Immune responses and outcome after vaccination with glioma-associated antigen peptides and poly-ICLC in a pilot study for pediatric recurrent low-grade gliomasaEuro
    Pollack, Ian F.
    Jakacki, Regina I.
    Butterfield, Lisa H.
    Hamilton, Ronald L.
    Panigrahy, Ashok
    Normolle, Daniel P.
    Connelly, Angela K.
    Dibridge, Sharon
    Mason, Gary
    Whiteside, Theresa L.
    Okada, Hideho
    [J]. NEURO-ONCOLOGY, 2016, 18 (08) : 1157 - 1168
  • [36] Antigen-Specific Immune Responses and Clinical Outcome After Vaccination With Glioma-Associated Antigen Peptides and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Children With Newly Diagnosed Malignant Brainstem and Nonbrainstem Gliomas
    Pollack, Ian F.
    Jakacki, Regina I.
    Butterfield, Lisa H.
    Hamilton, Ronald L.
    Panigrahy, Ashok
    Potter, Douglas M.
    Connelly, Angela K.
    Dibridge, Sharon A.
    Whiteside, Theresa L.
    Okada, Hideho
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (19) : 2050 - U99
  • [37] Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma
    Postow, Michael A.
    Chesney, Jason
    Pavlick, Anna C.
    Robert, Caroline
    Grossmann, Kenneth
    McDermott, David
    Linette, Gerald P.
    Meyer, Nicolas
    Giguere, Jeffrey K.
    Agarwala, Sanjiv S.
    Shaheen, Montaser
    Ernstoff, Marc S.
    Minor, David
    Salama, April K.
    Taylor, Matthew
    Ott, Patrick A.
    Rollin, Linda M.
    Horak, Christine
    Gagnier, Paul
    Wolchok, Jedd D.
    Hodi, F. Stephen
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (21) : 2006 - 2017
  • [38] Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis
    Sawamiphak, Suphansa
    Seidel, Sascha
    Essmann, Clara L.
    Wilkinson, George A.
    Pitulescu, Mara E.
    Acker, Till
    Acker-Palmer, Amparo
    [J]. NATURE, 2010, 465 (7297) : 487 - U115
  • [39] EphA and ephrin-A proteins regulate integrin-mediated T lymphocyte interactions
    Sharfe, Nigel
    Nikolic, Martina
    Cimpeon, Lorand
    De Kratts, Alison Van
    Freywald, Andrew
    Roifman, Chaim M.
    [J]. MOLECULAR IMMUNOLOGY, 2008, 45 (05) : 1208 - 1220
  • [40] Storkus W, 2016, DENDRITIC CELL VACCI